Europe Competent Cells Market Size, Share & Trends Analysis Report By Type, By Application (Cloning, Protein Expression, Mutagenesis, and Others), By End-Use, By Country and Growth Forecast, 2024

List of Tables

The Europe Competent Cells Market would witness market growth of 7.5% CAGR during the forecast period (2024-2031).

The Germany market dominated the Europe Competent Cells Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $248.4 million by 2031. The UK market is exhibiting a CAGR of 6.6% during (2024 - 2031). Additionally, The France market would experience a CAGR of 8.7% during (2024 - 2031).

These cells are used in the biopharmaceutical and biotechnology industries to produce recombinant proteins in therapeutic drugs, vaccines, and industrial enzymes. They provide a robust platform for scaling protein production, ensuring high yields, and maintaining protein quality and functionality. With the advent of technologies like CRISPR/Cas9, these cells are indispensable for genetic engineering and genome editing applications.

Adopting these cells in the biotechnology and life sciences industries is influenced by several key market dynamics, reflecting their critical role in advancing scientific research, biopharmaceutical development, and industrial applications. The biopharmaceutical sector is a major driver of these cell adoption. As the demand for biologics, including therapeutic proteins, monoclonal antibodies, and vaccines, continues to rise, so does the need for efficient and reliable protein expression and production systems. These cells provide a foundational platform for producing recombinant proteins in diagnostics and therapies.

Belgium's pharmaceutical industry increasingly focuses on biopharmaceuticals, including therapeutic proteins, monoclonal antibodies, and vaccines. As a result, Belgium is home to 29 of the world's top 30 pharmaceutical companies, including important subsidiaries of major U.S. companies such as Johnson and Johnson and Pfizer. The expansion of biopharmaceutical manufacturing in Belgium leads to a higher demand for these cells, particularly strains optimized for protein expression and high yield production. This trend boosts market growth for competent cell suppliers catering to the biotechnology and pharmaceutical sectors. Furthermore, The UK life sciences sector is advancing biopharmaceutical development, focusing on innovative therapies, vaccines, and personalized medicine. According to the UK Government, the number of life sciences firms in the UK has steadily risen since the 2008/09 fiscal year, reaching 6,850 in 2021/22. These companies operated from 7,910 sites across the UK, marking a 1% increase compared to the previous year. The turnover generated by UK life sciences businesses amounted to £108.1 billion in 2021/22, reflecting a 13% rise from the turnover of £95.9 billion (in 2021/22 prices) recorded in 2020/21. Hence, the increasing pharmaceutical industry and life science sector in the region are driving the market's growth.

Based on Type, the market is segmented into Chemically Competent Cells, Electrocompetent Cells, and Ultracompetent Cells. Based on Application, the market is segmented into Cloning, Protein Expression, Mutagenesis, and Others. Based on End-Use, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled

Thermo Fisher Scientific, Inc.
Merck KGaA
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Promega Corporation
New England Biolabs, Inc.
Qiagen N.V
F. Hoffmann-La Roche Ltd.
Takara Bio Inc. (Takara Holdings Inc.)
Lonza Group Ltd. (Capsugel)

Europe Competent Cells Market Report Segmentation

By Type

Chemically Competent Cells
Electrocompetent Cells
Ultracompetent Cells

By Application

Cloning
Protein Expression
Mutagenesis
Others

By End-Use

Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Others

By Country

Germany
UK
France
Russia
Spain
Italy
Rest of Europe

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 Europe Competent Cells Market, by Type
- 1.4.2 Europe Competent Cells Market, by Application
- 1.4.3 Europe Competent Cells Market, by End-Use
- 1.4.4 Europe Competent Cells Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key Highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. Strategies Deployed in Competent Cells Market

Chapter 5. Europe Competent Cells Market by Type

5.1 Europe Chemically Competent Cells Market by Country
5.2 Europe Electrocompetent Cells Market by Country
5.3 Europe Ultracompetent Cells Market by Country

Chapter 6. Europe Competent Cells Market by Application

6.1 Europe Cloning Market by Country
6.2 Europe Protein Expression Market by Country
6.3 Europe Mutagenesis Market by Country
6.4 Europe Others Market by Country

Chapter 7. Europe Competent Cells Market by End-Use

7.1 Europe Pharmaceutical & Biotechnology Companies Market by Country
7.2 Europe Academic & Research Institutes Market by Country
7.3 Europe Others Market by Country

Chapter 8. Europe Competent Cells Market by Country

8.1 Germany Competent Cells Market
- 8.1.1 Germany Competent Cells Market by Type
- 8.1.2 Germany Competent Cells Market by Application
- 8.1.3 Germany Competent Cells Market by End-Use
8.2 UK Competent Cells Market
- 8.2.1 UK Competent Cells Market by Type
- 8.2.2 UK Competent Cells Market by Application
- 8.2.3 UK Competent Cells Market by End-Use
8.3 France Competent Cells Market
- 8.3.1 France Competent Cells Market by Type
- 8.3.2 France Competent Cells Market by Application
- 8.3.3 France Competent Cells Market by End-Use
8.4 Russia Competent Cells Market
- 8.4.1 Russia Competent Cells Market by Type
- 8.4.2 Russia Competent Cells Market by Application
- 8.4.3 Russia Competent Cells Market by End-Use
8.5 Spain Competent Cells Market
- 8.5.1 Spain Competent Cells Market by Type
- 8.5.2 Spain Competent Cells Market by Application
- 8.5.3 Spain Competent Cells Market by End-Use
8.6 Italy Competent Cells Market
- 8.6.1 Italy Competent Cells Market by Type
- 8.6.2 Italy Competent Cells Market by Application
- 8.6.3 Italy Competent Cells Market by End-Use
8.7 Rest of Europe Competent Cells Market
- 8.7.1 Rest of Europe Competent Cells Market by Type
- 8.7.2 Rest of Europe Competent Cells Market by Application
- 8.7.3 Rest of Europe Competent Cells Market by End-Use

Chapter 9. Company Profiles

9.1 Thermo Fisher Scientific, Inc.
- 9.1.1 Company Overview
- 9.1.2 Financial Analysis
- 9.1.3 Segmental and Regional Analysis
- 9.1.4 Research & Development Expenses
- 9.1.5 Recent strategies and developments:
  - 9.1.5.1 Partnerships, Collaborations, and Agreements:
  - 9.1.5.2 Product Launches and Product Expansions:
  - 9.1.5.3 Geographical Expansions:
- 9.1.6 SWOT Analysis
9.2 Merck KGaA
- 9.2.1 Company Overview
- 9.2.2 Financial Analysis
- 9.2.3 Segmental and Regional Analysis
- 9.2.4 Research & Development Expense
- 9.2.5 Recent strategies and developments:
  - 9.2.5.1 Partnerships, Collaborations, and Agreements:
- 9.2.6 SWOT Analysis
9.3 Agilent Technologies, Inc.
- 9.3.1 Company Overview
- 9.3.2 Financial Analysis
- 9.3.3 Segmental and Regional Analysis
- 9.3.4 Research & Development Expense
- 9.3.5 Recent strategies and developments:
  - 9.3.5.1 Trail and Approvals:
- 9.3.6 SWOT Analysis
9.4 Bio-Rad laboratories, Inc.
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
- 9.4.3 Segmental and Regional Analysis
- 9.4.4 Research & Development Expenses
- 9.4.5 SWOT Analysis
9.5 Promega Corporation
- 9.5.1 Company Overview
- 9.5.2 Recent strategies and developments:
  - 9.5.2.1 Partnerships, Collaborations, and Agreements:
- 9.5.3 SWOT Analysis
9.6 New England Biolabs, Inc.
- 9.6.1 Company Overview
- 9.6.2 SWOT Analysis
9.7 Qiagen N.V.
- 9.7.1 Company Overview
- 9.7.2 Financial Analysis
- 9.7.3 Regional Analysis
- 9.7.4 Research & Development Expenses
- 9.7.5 SWOT Analysis
9.8 F. Hoffmann-La Roche Ltd.
- 9.8.1 Company Overview
- 9.8.2 Financial Analysis
- 9.8.3 Segmental and Regional Analysis
- 9.8.4 Research & Development Expense
- 9.8.5 SWOT Analysis
9.9 Takara Bio Inc. (Takara Holdings Inc.)
- 9.9.1 Company Overview
- 9.9.2 Financial Analysis
- 9.9.3 Segmental and Regional Analysis
- 9.9.4 Research & Development Expenses
9.10. Lonza Group Ltd. (Capsugel)
- 9.10.1 Company Overview
- 9.10.2 Financial Analysis
- 9.10.3 Segmental and Regional Analysis
- 9.10.4 Research & Development Expenses
- 9.10.5 SWOT Analysis

LIST OF TABLES

TABLE 1 Europe Competent Cells Market, 2020 - 2023, USD Million
TABLE 2 Europe Competent Cells Market, 2024 - 2031, USD Million
TABLE 3 Europe Competent Cells Market by Type, 2020 - 2023, USD Million
TABLE 4 Europe Competent Cells Market by Type, 2024 - 2031, USD Million
TABLE 5 Europe Chemically Competent Cells Market by Country, 2020 - 2023, USD Million
TABLE 6 Europe Chemically Competent Cells Market by Country, 2024 - 2031, USD Million
TABLE 7 Europe Electrocompetent Cells Market by Country, 2020 - 2023, USD Million
TABLE 8 Europe Electrocompetent Cells Market by Country, 2024 - 2031, USD Million
TABLE 9 Europe Ultracompetent Cells Market by Country, 2020 - 2023, USD Million
TABLE 10 Europe Ultracompetent Cells Market by Country, 2024 - 2031, USD Million
TABLE 11 Europe Competent Cells Market by Application, 2020 - 2023, USD Million
TABLE 12 Europe Competent Cells Market by Application, 2024 - 2031, USD Million
TABLE 13 Europe Cloning Market by Country, 2020 - 2023, USD Million
TABLE 14 Europe Cloning Market by Country, 2024 - 2031, USD Million
TABLE 15 Europe Protein Expression Market by Country, 2020 - 2023, USD Million
TABLE 16 Europe Protein Expression Market by Country, 2024 - 2031, USD Million
TABLE 17 Europe Mutagenesis Market by Country, 2020 - 2023, USD Million
TABLE 18 Europe Mutagenesis Market by Country, 2024 - 2031, USD Million
TABLE 19 Europe Others Market by Country, 2020 - 2023, USD Million
TABLE 20 Europe Others Market by Country, 2024 - 2031, USD Million
TABLE 21 Europe Competent Cells Market by End-Use, 2020 - 2023, USD Million
TABLE 22 Europe Competent Cells Market by End-Use, 2024 - 2031, USD Million
TABLE 23 Europe Pharmaceutical & Biotechnology Companies Market by Country, 2020 - 2023, USD Million
TABLE 24 Europe Pharmaceutical & Biotechnology Companies Market by Country, 2024 - 2031, USD Million
TABLE 25 Europe Academic & Research Institutes Market by Country, 2020 - 2023, USD Million
TABLE 26 Europe Academic & Research Institutes Market by Country, 2024 - 2031, USD Million
TABLE 27 Europe Others Market by Country, 2020 - 2023, USD Million
TABLE 28 Europe Others Market by Country, 2024 - 2031, USD Million
TABLE 29 Europe Competent Cells Market by Country, 2020 - 2023, USD Million
TABLE 30 Europe Competent Cells Market by Country, 2024 - 2031, USD Million
TABLE 31 Germany Competent Cells Market, 2020 - 2023, USD Million
TABLE 32 Germany Competent Cells Market, 2024 - 2031, USD Million
TABLE 33 Germany Competent Cells Market by Type, 2020 - 2023, USD Million
TABLE 34 Germany Competent Cells Market by Type, 2024 - 2031, USD Million
TABLE 35 Germany Competent Cells Market by Application, 2020 - 2023, USD Million
TABLE 36 Germany Competent Cells Market by Application, 2024 - 2031, USD Million
TABLE 37 Germany Competent Cells Market by End-Use, 2020 - 2023, USD Million
TABLE 38 Germany Competent Cells Market by End-Use, 2024 - 2031, USD Million
TABLE 39 UK Competent Cells Market, 2020 - 2023, USD Million
TABLE 40 UK Competent Cells Market, 2024 - 2031, USD Million
TABLE 41 UK Competent Cells Market by Type, 2020 - 2023, USD Million
TABLE 42 UK Competent Cells Market by Type, 2024 - 2031, USD Million
TABLE 43 UK Competent Cells Market by Application, 2020 - 2023, USD Million
TABLE 44 UK Competent Cells Market by Application, 2024 - 2031, USD Million
TABLE 45 UK Competent Cells Market by End-Use, 2020 - 2023, USD Million
TABLE 46 UK Competent Cells Market by End-Use, 2024 - 2031, USD Million
TABLE 47 France Competent Cells Market, 2020 - 2023, USD Million
TABLE 48 France Competent Cells Market, 2024 - 2031, USD Million
TABLE 49 France Competent Cells Market by Type, 2020 - 2023, USD Million
TABLE 50 France Competent Cells Market by Type, 2024 - 2031, USD Million
TABLE 51 France Competent Cells Market by Application, 2020 - 2023, USD Million
TABLE 52 France Competent Cells Market by Application, 2024 - 2031, USD Million
TABLE 53 France Competent Cells Market by End-Use, 2020 - 2023, USD Million
TABLE 54 France Competent Cells Market by End-Use, 2024 - 2031, USD Million
TABLE 55 Russia Competent Cells Market, 2020 - 2023, USD Million
TABLE 56 Russia Competent Cells Market, 2024 - 2031, USD Million
TABLE 57 Russia Competent Cells Market by Type, 2020 - 2023, USD Million
TABLE 58 Russia Competent Cells Market by Type, 2024 - 2031, USD Million
TABLE 59 Russia Competent Cells Market by Application, 2020 - 2023, USD Million
TABLE 60 Russia Competent Cells Market by Application, 2024 - 2031, USD Million
TABLE 61 Russia Competent Cells Market by End-Use, 2020 - 2023, USD Million
TABLE 62 Russia Competent Cells Market by End-Use, 2024 - 2031, USD Million
TABLE 63 Spain Competent Cells Market, 2020 - 2023, USD Million
TABLE 64 Spain Competent Cells Market, 2024 - 2031, USD Million
TABLE 65 Spain Competent Cells Market by Type, 2020 - 2023, USD Million
TABLE 66 Spain Competent Cells Market by Type, 2024 - 2031, USD Million
TABLE 67 Spain Competent Cells Market by Application, 2020 - 2023, USD Million
TABLE 68 Spain Competent Cells Market by Application, 2024 - 2031, USD Million
TABLE 69 Spain Competent Cells Market by End-Use, 2020 - 2023, USD Million
TABLE 70 Spain Competent Cells Market by End-Use, 2024 - 2031, USD Million
TABLE 71 Italy Competent Cells Market, 2020 - 2023, USD Million
TABLE 72 Italy Competent Cells Market, 2024 - 2031, USD Million
TABLE 73 Italy Competent Cells Market by Type, 2020 - 2023, USD Million
TABLE 74 Italy Competent Cells Market by Type, 2024 - 2031, USD Million
TABLE 75 Italy Competent Cells Market by Application, 2020 - 2023, USD Million
TABLE 76 Italy Competent Cells Market by Application, 2024 - 2031, USD Million
TABLE 77 Italy Competent Cells Market by End-Use, 2020 - 2023, USD Million
TABLE 78 Italy Competent Cells Market by End-Use, 2024 - 2031, USD Million
TABLE 79 Rest of Europe Competent Cells Market, 2020 - 2023, USD Million
TABLE 80 Rest of Europe Competent Cells Market, 2024 - 2031, USD Million
TABLE 81 Rest of Europe Competent Cells Market by Type, 2020 - 2023, USD Million
TABLE 82 Rest of Europe Competent Cells Market by Type, 2024 - 2031, USD Million
TABLE 83 Rest of Europe Competent Cells Market by Application, 2020 - 2023, USD Million
TABLE 84 Rest of Europe Competent Cells Market by Application, 2024 - 2031, USD Million
TABLE 85 Rest of Europe Competent Cells Market by End-Use, 2020 - 2023, USD Million
TABLE 86 Rest of Europe Competent Cells Market by End-Use, 2024 - 2031, USD Million
TABLE 87 Key Information - Thermo Fisher Scientific, Inc.
TABLE 88 key Information - Merck KGaA
TABLE 89 key Information - Agilent Technologies, Inc.
TABLE 90 Key Information - Bio-Rad Laboratories, Inc.
TABLE 91 key Information - Promega Corporation
TABLE 92 Key Information - New England BioLabs, Inc.
TABLE 93 Key Information - Qiagen N.V.
TABLE 94 Key Information - F. Hoffmann-La Roche Ltd.
TABLE 95 Key Information - Takara Bio Inc.
TABLE 96 Key Information -Lonza Group Ltd.

Europe Competent Cells Market Size, Share & Trends Analysis Report By Type, By Application (Cloning, Protein Expression, Mutagenesis, and Others), By End-Use, By Country and Growth Forecast, 2024 - 2031

Description

Table of Contents